Cargando…
Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
The huge prognostic difference between early and late stage hepatocellular carcinoma (HCC) is a challenging diagnostic problem. Alpha-fetoprotein is the mostly widely used biomarker for HCC used in the clinic, however it’s sensitivity and specificity of is not optimal. The development and applicatio...
Autores principales: | Liu, Xiao-Na, Cui, Dan-Ni, Li, Yu-Fang, Liu, Yun-He, Liu, Gang, Liu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700689/ https://www.ncbi.nlm.nih.gov/pubmed/31435173 http://dx.doi.org/10.3748/wjg.v25.i30.4199 |
Ejemplares similares
-
Biomarkers for hepatocellular carcinoma based on body fluids and feces
por: Guan, Ming-Cheng, et al.
Publicado: (2021) -
Bile acids as drivers and biomarkers of hepatocellular carcinoma
por: Colosimo, Santo, et al.
Publicado: (2022) -
Integrated Multiple “-omics” Data Reveal Subtypes of Hepatocellular Carcinoma
por: Liu, Gang, et al.
Publicado: (2016) -
Ablative strategies for recurrent hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2023) -
Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma
por: Zhao, Yang, et al.
Publicado: (2021)